These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 2853140)
1. Effects of 7,12-dimethylbenz[a]anthracene, benzo[a]pyrene and cyclosporin A on murine cytomegalovirus infection: studies of resistance mechanisms. Selgrade MJ; Daniels MJ; Burleson GR; Lauer LD; Dean JH Int J Immunopharmacol; 1988; 10(7):811-8. PubMed ID: 2853140 [TBL] [Abstract][Full Text] [Related]
2. Correlation between chemical suppression of natural killer cell activity in mice and susceptibility to cytomegalovirus: rationale for applying murine cytomegalovirus as a host resistance model and for interpreting immunotoxicity testing in terms of risk of disease. Selgrade MK; Daniels MJ; Dean JH J Toxicol Environ Health; 1992 Sep; 37(1):123-37. PubMed ID: 1326057 [TBL] [Abstract][Full Text] [Related]
3. Immunosuppression following 7,12-dimethylbenz[a]anthracene exposure in B6C3F1 mice--II. Altered cell-mediated immunity and tumor resistance. Dean JH; Ward EC; Murray MJ; Lauer LD; House RV; Stillman W; Hamilton TA; Adams DO Int J Immunopharmacol; 1986; 8(2):189-98. PubMed ID: 3086244 [TBL] [Abstract][Full Text] [Related]
4. Effects of immunosuppression with cyclophosphamide on acute murine cytomegalovirus infection and virus-augmented natural killer cell activity. Selgrade MK; Daniels MJ; Hu PC; Miller FJ; Graham JA Infect Immun; 1982 Dec; 38(3):1046-55. PubMed ID: 6295940 [TBL] [Abstract][Full Text] [Related]
5. The effect of cyclosporin on major histocompatibility complex-linked resistance to murine cytomegalovirus. Lawson CM; Hodgkin PD; Shellam GR J Gen Virol; 1989 May; 70 ( Pt 5)():1253-9. PubMed ID: 2543779 [TBL] [Abstract][Full Text] [Related]
6. Suppression of splenic lymphocyte function by 7,12-dimethylbenz[a]anthracene (DMBA) in vitro. Thurmond LM; House RV; Lauer LD; Dean JH Toxicol Appl Pharmacol; 1988 May; 93(3):369-77. PubMed ID: 2835829 [TBL] [Abstract][Full Text] [Related]
7. Suppression of murine cytotoxic T-lymphocyte induction following exposure to 7,12-dimethylbenz[A]anthracene: dysfunction of antigen recognition. House RV; Pallardy MJ; Dean JH Int J Immunopharmacol; 1989; 11(2):207-15. PubMed ID: 2495255 [TBL] [Abstract][Full Text] [Related]
8. Immunosuppression following exposure to 7,12-dimethylbenz[a]anthracene (DMBA) in Ah-responsive and Ah-nonresponsive mice. Thurmond LM; Lauer LD; House RV; Cook JC; Dean JH Toxicol Appl Pharmacol; 1987 Dec; 91(3):450-60. PubMed ID: 3122368 [TBL] [Abstract][Full Text] [Related]
9. Comparative dose-response tumorigenicity studies of dibenzo[alpha,l]pyrene versus 7,12-dimethylbenz[alpha]anthracene, benzo[alpha]pyrene and two dibenzo[alpha,l]pyrene dihydrodiols in mouse skin and rat mammary gland. Cavalieri EL; Higginbotham S; RamaKrishna NV; Devanesan PD; Todorovic R; Rogan EG; Salmasi S Carcinogenesis; 1991 Oct; 12(10):1939-44. PubMed ID: 1934274 [TBL] [Abstract][Full Text] [Related]
10. Molecular genetic characterization of the distal NKC recombination hotspot and putative murine CMV resistance control locus. Scalzo AA; Wheat R; Dubbelde C; Stone L; Clark P; Du Y; Dong N; Stoll J; Yokoyama WM; Brown MG Immunogenetics; 2003 Sep; 55(6):370-8. PubMed ID: 12920489 [TBL] [Abstract][Full Text] [Related]
11. Benzo(a)pyrene and 7,12-dimethylbenz(a)anthrecene differentially affect bone marrow cells of the lymphoid and myeloid lineages. Galván N; Page TJ; Czuprynski CJ; Jefcoate CR Toxicol Appl Pharmacol; 2006 Jun; 213(2):105-16. PubMed ID: 16307768 [TBL] [Abstract][Full Text] [Related]
12. The effect of initiating doses of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene on the expression of PAH activating enzymes and its modulation by plant phenols. Szaefer H; Krajka-Kuźniak V; Baer-Dubowska W Toxicology; 2008 Sep; 251(1-3):28-34. PubMed ID: 18694800 [TBL] [Abstract][Full Text] [Related]
13. Effects of NiCl2 and CdCl2 on susceptibility to murine cytomegalovirus and virus-augmented natural killer cell and interferon responses. Daniels MJ; Ménache MG; Burleson GR; Graham JA; Selgrade MK Fundam Appl Toxicol; 1987 May; 8(4):443-53. PubMed ID: 2440751 [TBL] [Abstract][Full Text] [Related]
14. Murine cytomegalovirus infection can enhance hybrid resistance through modulation of host natural killer activity. Muluk SC; Hakim FT; Shearer GM J Immunol; 1990 Aug; 145(4):1113-9. PubMed ID: 2166108 [TBL] [Abstract][Full Text] [Related]
15. Suppression of the in vitro humoral immune response of mouse splenocytes by 7,12-dimethylbenz[a]anthracene metabolites and inhibition of immunosuppression by alpha-naphthoflavone. Ladics GS; Kawabata TT; White KL Toxicol Appl Pharmacol; 1991 Aug; 110(1):31-44. PubMed ID: 1908145 [TBL] [Abstract][Full Text] [Related]
16. Immunosuppression following 7,12-dimethylbenz[a]anthracene exposure in B6C3F1 mice. I. Effects on humoral immunity and host resistance. Ward EC; Murray MJ; Lauer LD; House RV; Irons R; Dean JH Toxicol Appl Pharmacol; 1984 Sep; 75(2):299-308. PubMed ID: 6433512 [TBL] [Abstract][Full Text] [Related]
17. The effect of biological response modifiers on chronic and latent murine cytomegalovirus infections. Okada M; Minamishima Y Microbiol Immunol; 1987; 31(5):435-47. PubMed ID: 2443815 [TBL] [Abstract][Full Text] [Related]
18. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo. Bukowski JF; Welsh RM J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125 [TBL] [Abstract][Full Text] [Related]
19. Tumor-initiating activity and carcinogenicity of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene at low doses in mouse skin. Higginbotham S; RamaKrishna NV; Johansson SL; Rogan EG; Cavalieri EL Carcinogenesis; 1993 May; 14(5):875-8. PubMed ID: 8504480 [TBL] [Abstract][Full Text] [Related]